INTRODUCTION
Troponin I (TnI) is a regulatory thin-filament protein which is expressed in striated muscle. Along with the other subunits of troponin and tropomyosin, it participates in the control of muscle activation by Ca# + [1, 2] . There are three known TnI genes that encode isoforms that are specific to muscle twitch type in mature animals [3] [4] [5] . Cardiac TnI isoform is restricted in its expression to atrial and ventricular cardiac muscle [4] . There is no evidence to suggest that the cardiac isoform is expressed in skeletal muscle at any developmental stage [6] . In contrast, the slow skeletal-muscle TnI gene is expressed in embryonic, fetal and neonatal cardiac muscle, as has been demonstrated in several species [4, [7] [8] [9] . As development proceeds during gestation, the relative content of cardiac TnI mRNA and protein increases severalfold in both atrial and ventricular tissues, as the slow skeletal-muscle TnI content decreases [4, 10, 11] . The developmental switch is not complete until 21-28 days postnatally in the rat [4] . Interestingly, the developmental gene switch of the two isoforms in heart is observed and qualitatively similar in both rodents and large mammals including the human [8] . This suggests that the mechanisms that regulate this gene may be common in the rodent and human heart.
In order to characterize the regulation of this cardiac-restricted and developmentally regulated gene, we have characterized the organization and regulatory regions of the rat cardiac TnI gene. The proximal promoter region had the strong ability to direct Abbreviations used : BNP, B naturetic peptide ; CAT, chloramphenicol acetyltransferase ; DMEM, Dulbecco's modified Eagle's medium ; EMSA, electrophoretic mobility-shift assays ; HepG2, Hepatoma G2 ; MHC, myosin heavy chain ; MLC-2, myosin light chain 2 ; TnI, troponin I ; TnC, troponin C ; TnT, troponin T.
* To whom correspondence should be addressed. The nucleotide sequence in Figure 1 has been submitted to the EMBL, GenBank and DDBJ Nucleotide Sequence Databases under the accession number U77354.
cardiocytes was noted with a plasmid that included the region spanning k896 to j45 of the troponin I genomic sequence. Cotransfection of GATA-4, a recently identified cardiac transcription factor, with troponin I-luciferase constructs permitted high levels of luciferase expression in non-cardiac cells. Electrophoretic mobility-shift assays demonstrated specific binding of GATA-4 to oligonucleotides representative of multiple sites of the troponin I sequence. Mutation of a proximal GATA-4 DNAbinding site decreased transcriptional activation in transfected cardiocytes. These results indicate that the proximal cardiac troponin I sequence is sufficient to support high levels of cardiacspecific gene expression and that the GATA-4 transcription factor regulates troponin I-luciferase expression in itro.
reporter gene expression in cardiac cells in itro. These results are in contrast with the skeletal-muscle TnI genes, in which intronic regulatory elements are important in the regulation of reporter gene activity both in itro and in i o [12] [13] [14] [15] . In addition, multiple DNA-binding sites for the GATA-4 transcription factor were found, and GATA-4 was noted to trans-activate this gene in i o. An intact proximal GATA site was necessary for transcriptional activation of the gene in itro.
MATERIALS AND METHODS

Genomic clones
Overlapping genomic clones were obtained from a rat genomic library in Lambda Dash purchased from Stratagene and from a P1 rat genomic library. The phage library was screened by filter hybridization of a random-primer-labelled [16] probe consisting of the rat cardiac cDNA [4] . A single clone containing a 5h portion of the gene was obtained. Subsequently, three clones were obtained by PCR screening of a P1 library [17] using primers from k77 to k58 and antisense to j112 to j133. This screening was performed by Genomic Systems (Manchester, MO, U.S.A.). To facilitate DNA sequencing, fragments digested with restriction enzymes or generated by PCR using the P1 clones as template were placed into pGEM-3Z or pGEM-4Z (Promega) or into TA cloning vector (Invitrogen). Dideoxy DNA sequencing [18] was performed by using Sequenase (US Biochemical) or by automated sequencing in the Johns Hopkins University Genetics Core facility. The cap site of the gene had been previously characterized by primer extension analysis [4] .
Plasmids
Chimaeric plasmids for use in transfection experiments were prepared using upstream regions of the rat cardiac TnI gene cloned into the promoterless vector pGL # Basic (Promega) which contains a luciferase reporter gene. Overlapping genomic subclones from the first genomic isolate were first prepared by cloning a 1n2 kb HindIII-EcoRI fragment and a 3 kb EcoRI fragment into pGEM-3Z. The plasmid k150TnIpGL # (k150 to j51) was constructed by digesting the 1n2 kb genomic subclone with ApaI (k150) and BstEII (j51), blunting with T4 polymerase, subcloning this into digested blunted pGEM-3Z vector, and subsequently placing the insert directionally into pGL # Basic digested with SmaI and SacI. The construct k524TnIpGL # (k524 to j51) was prepared by digesting a 1n2 kb HindIII-EcoRI genomic subclone with BstEII, blunting and subcloning the fragment into XhoI-digested blunted pGL # Basic. The orientation was confirmed by sequencing. Because of lack of unique convenient restriction sites, the subsequent subclones were made after using PCR to amplify a 577 bp fragment using the primers corresponding to k532 to k515 and antisense to j16 to j45, but containing an EcoRI site at the 3h end of the sequence. This fragment was subcloned into pCR TM II (Invitrogen) and subjected to sequencing. The fragment was then digested from the vector with BstEII and EcoRI generating a 565 bp fragment, and subcloned into plasmid 1n2 kb HindIIIEcoRI (genomic subclone) digested with BstEII and EcoRI. The plasmid k896TnIpGL # (k896 to j45) clone was prepared by digesting this chimaeric 1n2 kb clone with HindIII and EcoRI, blunting and cloning into XhoI-digested blunted pGL # Basic. Orientation was confirmed by sequencing. The plasmid k2000TnIpGL # was prepared by digesting k896TnIpGL # with KspI (k859) and SacI (in the 3h linker of pGL # Basic) and ligating an upstream 1 kb SacI-KspI fragment from the 3 kb EcoRI genomic subclone. Additional plasmids were purchased for use including pGL # Control (Promega), which served as a positive control, and cytomegalovirus-β-galactosidase (CMV-β-gal) (Clontech), which served as a control for transfection efficiency. The GATA-4 expression vector pMT # -GATA-4 was generously provided by Dr. David Wilson (Washington University, St. Louis, MO, U.S.A.) [19] . Site-directed mutagenesis of the TnI-luciferase clones was performed by the method of Deng and Nickoloff [20] using the Transformer TM kit (Clontech) and confirmed by restriction analysis and sequencing.
Cell culture
Rat cardiomyocyte cultures were prepared using a slight modification of the method of Engelmann et al. [21] . Hearts were removed under sterile conditions from 3-day-old neonatal rats, gently blotted and rinsed in PBS, and then finely minced. Stepwise digestion with collagenase (Wako) was performed by gently rotating the cells in a siliconized glass tube on a wheel in a 37 mC incubator. The supernatant was intermittently removed and spun to collect cells. The first two supernatant fractions were discarded as these contained predominantly non-cardiocytes. The cardiocyte fractions were pooled, filtered through nylon mesh, and then resuspended in the culture medium PC1 (Ventrex). The cells were plated at a density of 2i10'\60 mm plate. Over 90 % of the cells were beating within 36 h and stained positively with antibody to cardiac TnI. Hepatoma G2 (HepG2), C2C12, NIH 3T3 and COS 7 cells were maintained in Dulbecco's modified Eagle's medium (DMEM) with 10 % fetal calf serum.
Transfections
Cardiocytes were transfected by the use of the liposomal transfection reagent DOTAP (Boehringer-Mannheim), which resulted in higher transfection efficiency than the calcium phosphate method in these primary cells. On the day of isolation of the cardiocytes, 20 µg of test plasmid and 5 µg of CMV-β-gal were added to 50 µl of DOTAP per plate and incubated at room temperature for 10 min. All steps were carried out in duplicate. The mixture was added in a dropwise fashion to the cells and the cells were incubated for 18 h. The medium was then changed and the cells were harvested for assay 72 h after the initial incubation.
HepG2, NIH 3T3, COS 7 and C2C12 cells were transfected by calcium phosphate co-precipitation [22] . In the case of the HepG2 and NIH 3T3 cells, the cells were plated at a density of 2i10'\60 mm plate for transfection. C2C12 cells were plated at low density (1n5i10&) or high density (1n5i10') to produce myoblasts or myotubes respectively. Each precipitate contained 20 µg of test plasmid and 5 µg of CMV-β-gal plasmid. The day after plating, the cells were refed and incubated for 3 h. The cells were then incubated with precipitate for 4 h and subjected to a 3 min glycerol shock. The cells were then washed and refed. Cells were harvested in 72 h for assay, except for the C2C12 highdensity cells, which were refed with DMEM\10 % horse serum and harvested when fusion of myotubes was noted at 72-96 h. For co-transfection experiments with GATA-4, the calcium phosphate method was used. The precipitate contained 15 µg of test plasmid, 5 µg of either pMT # -GATA-4 or pMT # and 5 µg of CMV-β-gal plasmid per 60 mm plate. COS cells were transfected with 25 µg of either pMT # -GATA-4 or pMT # per 100 mm plate.
Assays
On the day of harvesting the cells were washed in Ca# + -free Mg# + -free PBS, and then lysed in 200 µl of 1% Triton lysis buffer (Analytical Luminescence). Untransfected cells were used as the blank for luciferase and galactosidase assays. Luciferase assays were performed on 20 µl of cell extract using the assay kit produced by Analytical Luminescence. Luminescence was measured in an Analytical Luminescence luminometer over 10 s. Samples that exceeded the linear range of the assay were diluted immediately and remeasured. To normalize between plates, β-galactosidase activity was measured in a 50 µl volume extract using standard methods [23] .
Preparation of extracts
Nuclear extracts were prepared from neonatal rat hearts using the method of Dignam [24] with minor modifications as described [25] . Extracts from COS cells transfected with pMT # -GATA-4 or pMT # were prepared by washing the cells, then scraping them into 25 µl per plate of 2i binding buffer (40 mM Hepes\NaOH, pH 7n8, 100 mM KCl, 20 % glycerol, 1n0 mM EDTA, 1n0 mM MgCl # ), and taken through three cycles of freeze-thaw lysis.
Electrophoretic mobility-shift assay ( EMSA )
EMSA was performed as previously described [25] . The sense and antisense strands of the oligonucleotides used are as noted in Table 1 . BNP spans a sequence from k103 to k80 of the rat B naturetic peptide gene [26] , TnIG spans k678 to k652 of the rat cardiac TnI gene and βe2 spans a TEF-1-binding site from k288 to k267 of the rat β-myosin heavy chain (MHC) gene [25] . Additional oligonucleotides from the rat cardiac TnI gene sequence include : TnIG 750 which contains a GATA motif at k750 on the sense stand and spans bases k760 to k735 ; TnIG 557 which contains a GATA motif at k557 on the antisense strand and spans from k568 to k545 ; TnIG 62 which contains a GATA motif at k62 on the antisense strand and spans from k75 to k50 ; TnIG 2 which contains a GATA motif at k2 on the antisense strand and spans from k14 to j11. The oligonucleotides were generally synthesized with BamHI\Bgl II overhangs except as noted in Table 1 . Oligonucleotides were synthesized with mutations as noted in Table 1 . For competition studies a 200-fold molar excess of unlabelled competitor was used. Approx. 4-6 µg of extract was used per lane, and the results were analysed on a 6 % polyacrylamide gel.
RESULTS
Gene structure and putative regulatory motifs
The TnI gene structure and DNA sequence derived from the rat genomic clones are shown in Figure 1 . The gene has eight exons. Exon 2 is only 13 bp in length. In contrast with the avian fast skeletal-muscle TnI gene and the human slow skeletal-muscle TnI gene, the first exon of the cardiac TnI gene contains the start codon. The avian fast skeletal-muscle, rat and human slow skeletal-muscle TnI genes, like several other muscle-specific genes, have a first exon that is untranslated [12, 13, 27, 28] . The intron-exon structure of the avian fast skeletal-muscle, the human slow skeletal-muscle and rat and mouse cardiac genes are completely conserved for exons 5, 6 and 7, which encode the majority of the protein sequence [13, 29] . The structure and boundaries of exon 4 are also conserved between the slow skeletal-muscle and cardiac genes [13, 29] . Exon 8 includes the stop codon and untranslated region in the fast skeletal-muscle and cardiac genes ; however, the slow skeletal-muscle gene contains its 3h-untranslated region on a separate ninth exon [29] . The unique N-terminus of the cardiac TnI gene is encoded on exons 1, 2 and 3. Exon 3 includes the sequence for the functionally important serines which are phosphorylated by protein kinase A [30] . The ' inhibitory ' region of the protein (amino acids 129-149 in the rat cDNA sequence), which as a peptide is capable of inhibiting actomyosin ATPase activity [31] , is contained within exon 7 in all members of the gene family. The cysteines that interact with troponin T (TnT) [32] are split between exons 5 and 6.
In order to look for putative cardiac regulatory elements, computer searches of the 5h regions of the rat cardiac TnI gene were performed. No homology was found with the cardiac regulatory motif HF-1 described by Zhu et al. [33] , or the region said to confer cardiac-specificity on the cardiac TnT gene [34] . There was also no MEF-2 (YTAAAAATAACYYY) consensus site [35] , although an AT-rich motif (AAATAAA) was found at position k538. No M-CAT (CATTCCT) motif [36] , CArG box (CCWWWWWWGG) [37] , βe2 motif (TGTGGAATGT) [25] , AP-1 site (STGACTVA) [38] or CAAT box was found. There are E-boxes at positions k435, k380 and k283, and CACCC motifs at positions k690, k470 and k128 on the antisense strand and k73 on the sense strand. Expression of TnI mRNA is influenced by thyroid status in neonatal rat pups [39] . The cardiac TnI mRNA content was approximately twice as high in euthyroid rat pups as in hypothyroid rat pups. Computer searches of the 1 kb upstream region revealed three thyroid-responsive element half-sites at positions k545, k42 and j51. The lack of complete palindromes makes it unlikely that these sites are transcriptionally active. Five GATA motifs were found in the upstream sequence at k750 on the sense strand and k658, k557, k62 and k2 on the antisense strand. Only the motif at k2 meets the requirements for a consensus GATA motif [40] .
Figure 1 Sequence of the upstream region and the rat cardiac TnI gene
The TATA box at bp k31 is underlined. The cap site, as determined by primer extension analysis, is indicated in bold and underlined. Exons are displayed in upper case, and intervening and upstream sequence in lower case. Splice sites are underlined and in bold. The translated amino acid sequence is indicated by the single amino acid code on the line underneath the DNA sequence. These sequence data are available from GenBank/EMBL/DDBJ under accession number U77354.
Regulation of cardiac-specific expression
Transient transfection experiments were used to examine upstream regions of the cardiac TnI gene which regulate cardiac specificity. TnI-luciferase reporter gene constructs were used to transfect cell lines as well as primary cardiocytes. A schematic of the reporter gene plasmids is illustrated in Figure 2 . The results of these assays are compiled in Table 2 . All of the TnI-luciferase constructs were preferentially active in cardiocytes, but the k896TnIpGL # construct, in particular, demonstrated high levels of luciferase activity, over 7-fold that of the positive control vector pGL # Control and 33-fold the activity in the hepatoma cell line HepG2. All other cells types, including the myogenic line C2C12, demonstrated relatively low luciferase activity. The k2000TnIpGL # exhibited lower activity than k896TnIpGL # , suggesting that there may be a suppressor in this region. The region that contributes most strongly to positive transcriptional regulation (k896 to k525) did not contain the E-box motifs, or other known cardiac regulatory motifs, although this region did contain three GATA motifs at positions k750, k658 and k557 and GATA-like motifs (GATT) at positions k669 and k665 (Figure 2 ).
GATA-4 activates cardiac TnI-luciferase in non-cardiocytes
Because GATA-4 has recently been identified as a cardiac transcription factor [19] , its ability to trans-activate the cardiac TnI gene was examined. After trials at different ratios of GATA-4-expressing vector to reporter vector, a ratio of 1 : 3 GATA-4 to luciferase vector was found to be optimal. As illustrated in
Figure 2 Map of upstream region of the rat cardiac TnI gene and TnI-luciferase chimaeric plasmids
At the top is a map of the upstream region of the gene with the positions of the GATA, CACCC, E-box and TATA motifs indicated. Chimaeric plasmids with TnI upstream regions cloned into a luciferase (LUC) expression plasmid are illustrated below the schematic of the TnI gene. Control plasmids used in the transfection experiments include pGL 2 Basic which does not contain a promoter or enhancer and pGL 2 Control which contains a simian virus 40 (SV40) promoter and enhancer.
Table 2 Relative luciferase levels in cells transfected with cardiac TnI-luciferase fusion plasmids
Results are expressed relative to pGL 2 Control and are meanspS.E.M. for three to five independent transfections in which all plasmids were tested in parallel. They are normalized for β-galactosidase activity.
Luciferase activity (relative to pGL 2 Control) Cardiocytes  1n9p0n52  3n54p1n78  7n21p1n92  3n65p0n35  0n009p0n004  HepG2  0n39p0n10  0n57p0n10  0n22p0n10  0n72p0n16  0n001p0n0003  NIH3T3  0n18p0n04  0n17p0n04  0n17p0n03  0n19p0n05  0n002p0n001  C2C12MT  0n23p0n07  0n35p0n11  0n48p0n07  0n45p0n14  0n004p0n001  C2C12MB  0n78p0n23  1n9p1n4 1 n 2 p 0 n 54 0n97p0n50 0n017p0n003
Table 3 Effects of co-transfection of pMT 2 -GATA-4 on luciferase activity in NIH 3TE cells
The results are expressed relative to the positive control plasmid pGL 2 Control and are meanspS.E.M. for three experiments. They are normalized to β-galactosidase activity.
Luciferase activity (relative to pGL 2 Control) Table 3 , co-expression of GATA-4 in the NIH 3T3 cells resulted in a striking increase in the reporter gene activity in these cells relative to the control vector. The relative luciferase activity obtained in these co-transfected NIH 3T3 cells is comparable with that obtained in cardiocytes. This activation is most notable with the k896TnIpGL # construct which has 11-fold the activity of the pGL # Control vector, although the overall 6-7-fold increase compared with co-transfection with the control pMT # vector was similar for the k150TnIpGL # , k896TnIpGL # and k2000TnIpGL # plasmids. The k524TnIpGL # construct demonstrated only a 3n9-fold increase when compared with co-transfection with the control pMT # plasmid. 
Figure 3 Binding of the TnI probe containing three GAT( A/T ) motifs to nuclear protein from neonatal rat cardiac muscle and to GATA-4 expressed in COS cells
GATA-4 binds specifically to GAT( A/T ) motifs in the cardiac TnI sequence
An element from position k657 to k674 of the cardiac TnI gene contains a GATA motif and a GATA-like motif (GATT) in tandem on the antisense strand with spacing identical with tandem GATA motifs on the rat BNP gene [26] . These motifs are illustrated in Table 1 which specifies the oligonucleotides used in EMSA. There is also a GATT motif on the sense strand of this cardiac TnI element which lies between the two antisense GAT(A\T) motifs. These motifs are contained within the k896TnIpGL # construct which has the highest transcriptional activity in cardiocytes. EMSA was performed to assess DNAbinding activity to this region in cardiocytes and to examine whether GATA-4 expressed in COS cells would specifically bind to this probe. Nuclear extract from neonatal rat heart results in a gel shift of the TnI probe as illustrated in Figure 3 . Binding activity was competed for by either the TnI oligonucleotide (TnIG) or oligonucleotide from the rat BNP gene (Table 1 ). An unrelated oligonucleotide from the rat β-MHC gene ( βe2) did not compete. Extract from COS cells transfected with pMT # -GATA-4 complexed with the TnIG probe with the same gel-shift pattern. This activity was also competed for by either the TnIG or BNP probe. Extract from COS cells transfected with pMT # did not result in a gel shift. These data indicate that this element of the cardiac TnI gene, which contains GATA and GATA-like motifs, was able to complex specifically with GATA-4.
The effects of mutations of single bases in the GAT(A\T) sites in the TnIG probe were analysed in Figure 4 . An oligonucleotide containing mutations in all three GAT(A\T) motifs did not compete for binding to the probe. An oligonucleotide containing mutations in either flanking antisense motif and the sense motif did not compete for GATA-4 DNA binding. Oligonucleotides in which either both flanking antisense motifs or the sense GATT motif were intact were capable of competing GATA-4 DNA binding. The oligonucleotides which contained a single intact antisense motif did not compete for GATA-4 DNA binding.
Additional GATA sites complex with GATA-4 in vitro
The putative GATA DNA-binding sites at positions k750, k557, k62 and k2 were assessed by performing competition 2-7) . Competitions were performed with 200-fold molar excesses of unlabelled self (TnIG), an oligonucleotide with GATA site at k750 on the sense strand (TnIG 750), an oligonucleotide with a GATA site at k557 on the antisense strand (TnIG 557), an oligonucleotide with the GATA site at k62 on the antisense strand (TnIG 62) and an oligonucleotide with the GATA site at k2 on the antisense strand (TnIG 2). TnIG 750 and TnIG 2 compete for the binding of GATA-4 to the TnIG probe, whereas TnIG 557 and TnIG 62 compete weakly if at all. Figure 5 , demonstrated the ability of the unlabelled probes containing GATA sequences at k750 and k2 to compete for binding of GATA-4 to the TnIG probe containing three GAT(A\T) motifs. The ability of the TnI k2 GATA site to specifically bind GATA-4 was further assayed by labelling this probe and performing competition studies with specific and non-specific competitors as well as with a probe containing a single mutation in the GATA site (GATA to GGTA). The results are illustrated in Figure 6 . There is specific binding of the GATA-4-containing cell extract to the k2 GATA motif, and the single mutation resulted in loss of the ability of this oligonucleotide to compete for GATA-4 DNA binding.
EMSAs. The results, illustrated in
A mutation in the proximal GATA-4 site results in reduction of transcriptional activation
Transient transfection assays were performed on constructs containing the mutation that resulted in loss of competition of GATA-4 DNA binding to the k2 GATA site in the EMSA. . Competitions were performed with 200-fold molar excesses of unlabelled self (TnIG2), a probe containing a cluster of GATA sites at k669/665/658 (TnIG), the BNP gene probe containing paired GATA sites, an unrelated probe from the β-MHC gene ( βe2) and a TnIG 2 probe with a single mutation (GATA to GGTA). The TnIG 2 probe complexes with GATA-4 and this interaction is competed for by self, by the GATAbinding probes TnIG and BNP, but not by the non-specific probe βe2 or by a probe containing the mutated GATA site. Results in these functional assays demonstrate that this mutation reduces the luciferase activity of the k150TnIpGL # construct by 80 % in the transfected cardiocytes (Table 4 ). This effect was present in both the k150TnIpGL # and the k896TnIpGL # construct, indicating that an intact proximal GATA site is necessary to support transcriptional activity in cardiocytes.
DISCUSSION
This work demonstrates that the proximal promoter region of the rat cardiac TnI gene is sufficient to support high levels of reporter gene activity in cardiocytes and demonstrates relatively low activity in non-muscle and skeletal-muscle cell lines. In this regard, the cardiac TnI gene differs from the fast and slow skeletal-muscle family members, which like other muscle genes, require intronic regions to mediate high levels of expression [12] [13] [14] [15] . The finding that the proximal upstream region supports high levels of reporter gene activity in cardiocytes is not unexpected given the reports of other investigators noting that the cardiac-specific regulation of genes, such as myosin light chain 2 (MLC-2) and troponin C (TnC), may be mediated by immediate upstream regions [33, 41] . This study is limited in that the contribution of 3h regions of the cardiac TnI gene have not been assessed.
Although it is difficult to compare studies utilizing different reporter genes, this report contrasts with that of Ausoni et al. [29] , who reported relatively poor activity of similar constructs of the mouse TnI gene in their transient transfection experiments. These authors noted that mouse cardiac TnI-chloramphenicol acetyltransferase (CAT) constructs were at most capable of supporting activity that was an order of magnitude less than pSV # CAT. In the present experiments the cardiac TnI-luciferase constructs exceeded the activity of the pGL # Control by up to 7-fold. It is possible that the relatively lower activity reported for transcriptional assays with the mouse promoter was due to the use of constructs in which the promoter was truncated a few base pairs downstream from the conserved proximal GATA site [29] . Furthermore, no specific regulatory elements in the mouse cardiac TnI promoter were defined in that study.
The results of these studies suggest that GATA-4 plays an important role in the regulation of the cardiac TnI gene. GATA-4 has recently been shown to be expressed in the precardiac mesoderm in the embryonic mouse heart starting at postcoital day 7n0 to 7n5, at day 8 in the developing heart tube and in rat neonatal cardiomyocytes [42, 43] . Thus its developmental pattern of expression temporally precedes that of cardiac TnI mRNA in rodent heart, suggesting that GATA-4 could mediate the developmental up-regulation of this gene [4, 44] . GATA-4 may also mediate effects of thyroid hormone on TnI expression. We had previously demonstrated that neonatal rats that were made hypothyroid had delayed switching of TnI isoforms [39] . Molkentin et al. [45] have demonstrated that exogenous thyroid hormone up-regulates GATA-4 DNA-binding activity 3-fold in neonatal cardiocytes, possibly explaining the delay in up-regulation of cardiac TnI mRNA in hypothyroid neonatal rat hearts.
Although other cis-acting cardiac regulatory elements have been characterized, GATA motifs in the α-MHC gene, the TnC gene and the rat BNP gene have been demonstrated to interact specifically with GATA-4 [26, 43, 45] . In the rat BNP gene, there is a proximal GATA-4 DNA-binding site at k30, as well as paired GATA-4 DNA-binding motifs at k90. Mutation of both of the paired upstream GATA motifs results in a 10-fold reduction in reporter gene activity of BNP constructs [26] . Mutation of the GATA site at the k30 position was not functionally assessed [26] . In addition, the presence of the paired upstream GATA motifs from the BNP gene activated a heterologous promoter in cardiocytes [26] . Expression of GATA-4 in non-muscle cell line was demonstrated to activate reporter gene constructs of the BNP and TnC genes ; however, GATA-4 was only capable of trans-activating the α-MHC reporter gene constructs in a skeletal-muscle context [26, 43, 45] .
Despite some similarities in the regulation of cardiac contractile protein genes by GATA-4, the developmental patterns of expression differ between TnI, TnC and α-MHC genes. TnC is the predominant isoform in heart throughout development, although there is transient expression of fast skeletal-muscle TnC in embryonic heart [46] . α-MHC is expressed in embryonic mouse heart tube between day 7n5 and 8 post coitum, but β-MHC predominates in fetal rodent heart [47] . Cardiac TnI mRNA is not detectable until a slightly later stage in rodent heart, and is preceded by expression of the slow skeletal-muscle TnI isoform in heart [44] . Although α-MHC is rapidly induced after birth in the rodent heart, cardiac TnI is not fully expressed until weaning [4] . Furthermore α-MHC is a minor isoform in human cardiac ventricle, whereas TnI isoform switching is highly similar between rodent and human heart [8] . Two recent studies have explored the role of GATA-4 in early cardiocyte differentiation. Grepin et al. [48] have suggested that GATA-4 plays a role in cardiac cell commitment, as evidenced by the lack of cardiocyte differentiation in P19 cells transfected with antisense GATA-4 constructs ; however, data from chimaeric mice created by blastocyst injection with embryonic stem cells with GATA-4 deleted indicates that these cells have the capacity to contribute to the myocardium [49] . By analogy with the roles of GATA and other transcription factors in haematopoietic lineages [50] , GATA-4 and other GATA proteins and cofactors in the heart may play a role in both early cardiocyte differentiation, as well as later stages of developmental regulation. In this regard the TnI gene family may be an excellent model system for dissecting the role of cardiac transcription factors at mid to late gestation as well as early postnatal life.
To date relatively few cardiac-restricted transcription factors have been defined. Other cardiac gene regulatory factors, such as TEF-1 and the MEF-2, are expressed in a variety of tissues, but DNA-binding activity is found predominantly in both forms of striated muscle [51] [52] [53] [54] . Although GATA-4 is expressed in the cardiac but not skeletal-muscle lineage, it is not strictly cardiacspecific in that it is expressed in gut and gonadal tissues. Additional GATA family members have been defined in the chicken and rat, which have overlapping but distinct patterns of expression in heart and gut [55, 56] . In the haematopoietic system, GATA factors may self-interact [57] , interact with or regulate other GATA factors [57, 58] or interact with ubiquitous or tissuespecific factors [59] . Similar complex interactions are likely to take place in the cardiovascular system.
Taken together these data indicate that the proximal regions of the cardiac TnI gene regulate its cardiac-specific expression.
Comparison of the regulatory regions of cardiac TnI with that of the fast and slow twitch skeletal-muscle TnI genes follows the pattern found in other contractile protein genes in which skeletalmuscle enhancers are located in intronic regions whereas those mediating high levels of cardiac expression are located in the proximal upstream regions. A proximal GATA-4-binding site in the cardiac TnI gene is necessary for the transcriptional activation of this gene in itro, and other sites of GATA-4 DNA binding may contribute to the regulation of this gene.
